{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-12-16&answer.answeringMemberConstituency=Battersea", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2014-12-16&answer.answeringMemberConstituency=Battersea", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-12-16&answer.answeringMemberConstituency=Battersea&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-12-16&_page=0&answer.answeringMemberConstituency=Battersea", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-12-16&answer.answeringMemberConstituency=Battersea", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-12-16&answer.answeringMemberConstituency=Battersea", "items" : [{"_about" : "http://data.parliament.uk/resources/170704", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170704/answer", "answerText" : {"_value" : "
It is not the case that indicators measuring the mortality rates of over 75s are excluded in the NHS Outcomes Framework. An overarching indicator in Domain 1, \u2018Life Expectancy at 75\u2019, is derived from mortality rates for people aged over 75 from all causes. This indicator captures premature mortality in a way that does not presume any age-determined limit to when a death is premature.<\/p>
<\/p>
<\/p>
<\/p>
The cause-specific mortality rate indicators are capped at age 75 because the attribution of the cause of death is more problematic for older people, who often have co-morbidities. Therefore, these indicators could become misleading if they included those aged 75 and above.<\/p>
<\/p>
<\/p>
<\/p>
However, the Department will keep under review outcome measures for older people as part of the next refresh of the NHS Outcomes Framework.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-07T17:35:29.57Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mortality Rates"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what recent discussions (a) his Department and (b) NHS England have had on the exclusion of indicators measuring over 75 mortality rates in the NHS Outcomes Framework.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3968", "label" : {"_value" : "Biography information for Stephen Lloyd"} } , "tablingMemberConstituency" : {"_value" : "Eastbourne"} , "tablingMemberPrinted" : [{"_value" : "Stephen Lloyd"} ], "uin" : "218941"} , {"_about" : "http://data.parliament.uk/resources/170706", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170706/answer", "answerText" : {"_value" : "
As the Government continues to consider carefully all issues relevant to the introduction of standardised packaging of tobacco products, the Department currently has no plans to place this information into the Library.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "218953"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-05T17:07:03.62Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tobacco: Packaging"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, if he will place in the Library copies of all correspondence between him, Ministers of his Department, officials of his Department and the European Commission on the Standardised Packaging of Tobacco Products Regulations, as notified by the UK Government to the Commission on 29 August 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/403", "label" : {"_value" : "Biography information for Mr Gerry Sutcliffe"} } , "tablingMemberConstituency" : {"_value" : "Bradford South"} , "tablingMemberPrinted" : [{"_value" : "Mr Gerry Sutcliffe"} ], "uin" : "218952"} , {"_about" : "http://data.parliament.uk/resources/170707", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170707/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation (JCVI), the body that advises the government on all immunisation matters has set up a human papillomavirus (HPV) sub-committee to consider a number of key issues on HPV vaccination, including the routine vaccination of adolescent boys.<\/p>
<\/p>
<\/p>
<\/p>
The HPV sub-committee will report its findings to the JCVI following consideration of work modelling the impact and cost-effectiveness of extending HPV vaccination to adolescent boys. We are advised that it is currently anticipated that a model being developed at Warwick University can be presented to the HPV sub-committee in the second half of 2015. A separate model being developed by Public Health England may not be completed until early 2017.<\/p>
<\/p>
<\/p>
<\/p>
We are furthermore advised that the JCVI and sub-committee may need to consider both studies before taking a final view on the impact and cost-effectiveness of extending HPV vaccination to adolescent boys and may therefore not be in a position to do so before early 2017.<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-05T17:59:38.463Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, when he expects the Joint Committee on Vaccination and Innoculation to make a recommendation on whether all adolescent boys should be included in the national HPV vaccination programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1390", "label" : {"_value" : "Biography information for Mr John Baron"} } , "tablingMemberConstituency" : {"_value" : "Basildon and Billericay"} , "tablingMemberPrinted" : [{"_value" : "Mr John Baron"} ], "uin" : "218969"} , {"_about" : "http://data.parliament.uk/resources/170709", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170709/answer", "answerText" : {"_value" : "
Information on the number of patients on the four Quality and Outcomes Framework registers containing a measure of cholesterol is set out in the attached tables for England and for each clinical commissioning group/primary care trust in England.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/170709/answer/attachment/1", "fileName" : {"_value" : "20141218 PQ218958 Simon Burns Cholesterol.xlsx"} , "title" : "Cholesterol measure tables"} , "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-05T16:05:09.25Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cholesterol"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what proportion of patients have been recorded through the Quality and Outcomes Framework as having total cholesterol at 5mmol/l or less in (a) England and (b) each local commissioning organisation in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/46", "label" : {"_value" : "Biography information for Sir Simon Burns"} } , "tablingMemberConstituency" : {"_value" : "Chelmsford"} , "tablingMemberPrinted" : [{"_value" : "Mr Simon Burns"} ], "uin" : "218958"} , {"_about" : "http://data.parliament.uk/resources/170710", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170710/answer", "answerText" : {"_value" : "
As the Government continues to consider carefully all issues relevant to the introduction of standardised packaging of tobacco products, the Department currently has no plans to place this information into the Library.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "218952"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-05T17:07:03.83Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tobacco: Packaging"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what recent discussions he, Ministers or officials of his Department have had with the European Commission on the Standardised Packaging of Tobacco Product Regulations, as notified by the Government to the Commission on 29 August 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/403", "label" : {"_value" : "Biography information for Mr Gerry Sutcliffe"} } , "tablingMemberConstituency" : {"_value" : "Bradford South"} , "tablingMemberPrinted" : [{"_value" : "Mr Gerry Sutcliffe"} ], "uin" : "218953"} , {"_about" : "http://data.parliament.uk/resources/170711", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/170711/answer", "answerText" : {"_value" : "
The following Member States provided detailed opinions; Romania, Greece, Italy, Lithuania, Poland, Portugal, Slovakia, Bulgaria, Czech Republic, Hungary, Spain. Ireland provided a comment.<\/p>
<\/p>
<\/strong><\/p> <\/p> Further information about member states respondes can be found at:<\/p> <\/p> <\/p> <\/p> http://ec.europa.eu/enterprise/tris/en/search/?trisaction=search.detail&year=2014&num=427<\/a><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-01-05T15:26:29.797Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Tobacco: Packaging"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether any EU member state has objected to the European Commission about the Standardised Packaging of Tobacco Product Regulations, as notified by the Government to the Commission on 29 August 2014; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/403", "label" : {"_value" : "Biography information for Mr Gerry Sutcliffe"}
}
, "tablingMemberConstituency" : {"_value" : "Bradford South"}
, "tablingMemberPrinted" : [{"_value" : "Mr Gerry Sutcliffe"}
], "uin" : "218954"}
, {"_about" : "http://data.parliament.uk/resources/170714", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/170714/answer", "answerText" : {"_value" : " Consultation both with clinical commissioning groups (CCGs) and the wider public concerning the transfer of commissioning responsibility of Renal Dialysis from NHS England to CCGs is ongoing.<\/p> <\/p> <\/p> <\/p> The Department has launched a public consultation which closes on 9 January 2015. The consultation considers how to transfer commissioning responsibility and what would need to happen to ensure a smooth transition and maintain both service standards and patient safety. All CCGs are invited to comment on the proposed changes.<\/p> <\/p> <\/p> <\/p>